Does ALPELISIB Cause Off label use? 159 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 159 reports of Off label use have been filed in association with ALPELISIB (PIQRAY). This represents 1.9% of all adverse event reports for ALPELISIB.
159
Reports of Off label use with ALPELISIB
1.9%
of all ALPELISIB reports
15
Deaths
33
Hospitalizations
How Dangerous Is Off label use From ALPELISIB?
Of the 159 reports, 15 (9.4%) resulted in death, 33 (20.8%) required hospitalization, and 10 (6.3%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALPELISIB. However, 159 reports have been filed with the FAERS database.
What Other Side Effects Does ALPELISIB Cause?
Hyperglycaemia (1,575)
Rash (1,393)
Diarrhoea (1,336)
Blood glucose increased (1,105)
Death (921)
Nausea (860)
Fatigue (817)
Decreased appetite (546)
Weight decreased (508)
Malignant neoplasm progression (497)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ALPELISIB Alternatives Have Lower Off label use Risk?
ALPELISIB vs ALPHA.-LIPOIC ACID
ALPELISIB vs ALPHA.-TOCOPHEROL
ALPELISIB vs ALPHA.-TOCOPHEROL, D-
ALPELISIB vs ALPHA.-TOCOPHEROL, DL-
ALPELISIB vs ALPHA.1-PROTEINASE INHIBITOR HUMAN